Effect of glucosamine in the treatment of psoriasis

Evaluation of the effect and side effects of topical glucosamine in the treatment of patients with plaque psoriasis

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200817048439N1

Enrollment

Registered

2020-10-18

Start date

2016-05-09

Completion date

Unknown

Last updated

2020-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psoriasis vulgaris. Psoriasis vulgaris

Interventions

Intervention 1: Glucosamine ointment: Topical glucosamine ointment was routinely used by patients twice a day on plaque lesions on one side of the body for a total of 8 weeks. Intervention 2: Placebo

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients of older than 18 years Patients with plaque psoriasis

Exclusion criteria

Exclusion criteria: Use of any topical or oral medication affecting the course of the disease in the last three months Irregular attendance for visits Occurrence of any complications

Design outcomes

Primary

Measure	Time frame
Psoriasis area and severity index (PASI). Timepoint: Every two weeks. Method of measurement: Calculated by the severity index and psoriasis area formula.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAhmadreza Taheri Bojd

Mashhad University of Medical Sciences

Taheriar@mums.ac.ir+98 51 3800 2000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026